Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2005 Jul 5

PMID 15994779

Citations 116

Authors

Anna Smed-Sorensen

Karin Lore

Jayanand Vasudevan

Mark K Louder

Jan Andersson

John R Mascola

Anna-Lena Spetz

Richard A Koup

Affiliations

Soon will be listed here.

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of dendritic cells (DCs) plays an important role in HIV-1 transmission and pathogenesis. Here, we studied the susceptibility of ex vivo-isolated CD11c+ myeloid DCs (MDCs) and CD123+ plasmacytoid DCs (PDCs) to HIV-1 infection and the function of these cells early after infection. Both DC subsets were susceptible to CCR5- and CXCR4-using HIV-1 isolates (BaL and IIIB, respectively). However, MDCs were more susceptible to HIV-1(BaL) infection than donor-matched PDCs. In addition, HIV-1(BaL) infected MDCs more efficiently than HIV-1(IIIB), whereas PDCs were equally susceptible to both isolates. While exposure to HIV-1 alone resulted in only weak maturation of DCs, Toll-like receptor 7/8 ligation induced full maturation in both infected and uninfected DCs. Maturation did not increase HIV-1 replication in infected DCs, and infected DCs retained their ability to produce tumor necrosis factor alpha after stimulation. Both HIV-1 isolates induced alpha interferon production exclusively in PDCs, irrespective of productive infection. In conclusion, PDCs and MDCs were susceptible to HIV-1 infection, but neither displayed functional defects as a consequence of infection. The difference in susceptibility of PDCs and MDCs to HIV-1 may have implications for HIV-1 transmission and DC-mediated transfer of HIV-1 to T cells.

Citing Articles

IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus.

Guney M, Nagalekshmi K, McCauley S, Carbone C, Aydemir O, Luban J Proc Natl Acad Sci U S A. 2024; 121(29):e2404349121.

PMID: 38985764 PMC: 11260138. DOI: 10.1073/pnas.2404349121.

IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus.

Guney M, Nagalekshmi K, McCauley S, Carbone C, Aydemir O, Luban J bioRxiv. 2023; .

PMID: 38014177 PMC: 10680824. DOI: 10.1101/2023.11.17.567619.

Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART.

Banga R, Procopio F, Lana E, Gladkov G, Roseto I, Parsons E Cell Host Microbe. 2023; 31(10):1714-1731.e9.

PMID: 37751747 PMC: 11068440. DOI: 10.1016/j.chom.2023.08.020.

Tissue-like environments shape functional interactions of HIV-1 with immature dendritic cells.

Gallucci L, Abele T, Fronza R, Stolp B, Laketa V, Sid Ahmed S EMBO Rep. 2023; 24(6):e56818.

PMID: 37042686 PMC: 10240187. DOI: 10.15252/embr.202356818.

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier.

Bell B, Bruun T, Friedland N, Kim P Proc Natl Acad Sci U S A. 2023; 120(8):e2215792120.

PMID: 36795752 PMC: 9974412. DOI: 10.1073/pnas.2215792120.

References

Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz A . HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood. 2004; 104(9):2810-7. DOI: 10.1182/blood-2003-07-2314. View

Kawamura T, Bruse S, Abraha A, Sugaya M, Hartley O, Offord R . PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes. J Virol. 2004; 78(14):7602-9. PMC: 434074. DOI: 10.1128/JVI.78.14.7602-7609.2004. View

Mascola J, Louder M, Surman S, Vancott T, Yu X, Bradac J . Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res Hum Retroviruses. 1996; 12(14):1319-28. DOI: 10.1089/aid.1996.12.1319. View

Charbonnier A, Verrier B, Jacquet C, Massacrier C, Fiers M, Mallet F . In vitro HIV1 infection of CD34+ progenitor-derived dendritic/Langerhans cells at different stages of their differentiation in the presence of GM-CSF/TNF alpha. Res Virol. 1996; 147(2-3):89-95. DOI: 10.1016/0923-2516(96)80221-4. View

Canque B, Rosenzwajg M, Camus S, Yagello M, Bonnet M, GUIGON M . The effect of in vitro human immunodeficiency virus infection on dendritic-cell differentiation and function. Blood. 1996; 88(11):4215-28. View

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

Patterson S, Robinson S, English N, Knight S . Subpopulations of peripheral blood dendritic cells show differential susceptibility to infection with a lymphotropic strain of HIV-1. Immunol Lett. 1999; 66(1-3):111-6. DOI: 10.1016/s0165-2478(98)00166-7. View

Canque B, Bakri Y, Camus S, Yagello M, Benjouad A, Gluckman J . The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage. Blood. 1999; 93(11):3866-75. View

Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B . Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS. 1999; 13(7):759-66. DOI: 10.1097/00002030-199905070-00004. View

10.

Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A . Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999; 5(8):919-23. DOI: 10.1038/11360. View

11.

Lore K, Sonnerborg A, Olsson J, Patterson B, Fehniger T, Perbeck L . HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. AIDS. 1999; 13(15):2013-21. DOI: 10.1097/00002030-199910220-00003. View

12.

Geijtenbeek T, Kwon D, Torensma R, van Vliet S, van Duijnhoven G, Middel J . DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000; 100(5):587-97. DOI: 10.1016/s0092-8674(00)80694-7. View

13.

Jahnsen F, Lund-Johansen F, Dunne J, Farkas L, Haye R, Brandtzaeg P . Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol. 2000; 165(7):4062-8. DOI: 10.4049/jimmunol.165.7.4062. View

14.

Lore K, Spetz A, Fehniger T, Sonnerborg A, Landay A, Andersson J . Quantitative single cell methods that identify cytokine and chemokine expression in dendritic cells. J Immunol Methods. 2001; 249(1-2):207-22. DOI: 10.1016/s0022-1759(01)00293-9. View

15.

Patterson S, Rae A, Hockey N, Gilmour J, Gotch F . Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol. 2001; 75(14):6710-3. PMC: 114396. DOI: 10.1128/JVI.75.14.6710-6713.2001. View

16.

Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen F . Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001; 159(1):237-43. PMC: 1850412. DOI: 10.1016/s0002-9440(10)61689-6. View

17.

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

18.

Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F . Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood. 2001; 98(8):2574-6. DOI: 10.1182/blood.v98.8.2574. View

19.

Jahnsen F, Moloney E, Hogan T, Upham J, Burke C, Holt P . Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax. 2001; 56(11):823-6. PMC: 1745967. DOI: 10.1136/thorax.56.11.823. View

20.

Feldman S, Stein D, Amrute S, Denny T, Garcia Z, Kloser P . Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol. 2001; 101(2):201-10. DOI: 10.1006/clim.2001.5111. View